共 209 条
[1]
Neogi T(2013)The epidemiology and impact of pain in osteoarthritis Osteoarthritis.Cartilage. 21 1145-1153
[2]
Bhala N(2013)Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials Lancet 382 769-779
[3]
Emberson J(2011)Antagonism of nerve growth factor-TrkA signaling and the relief of pain Anesthesiology 115 189-204
[4]
Merhi A(2012)Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial J Pain 13 790-798
[5]
Abramson S(2014)Efficacy and safety of intravenous tanezumab for the symptomatic treatment of osteoarthritis: 2 randomized controlled trials versus naproxen J Rheumatol 41 2249-2259
[6]
Arber N(2010)Tanezumab for the treatment of pain from osteoarthritis of the knee NEnglJ Med 363 1521-1531
[7]
Baron JA(2011)Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study Osteoarthritis Cartilage. 19 1405-12
[8]
Bombardier C(2003)Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response Clin Exp.Rheumatol. 21 617-624
[9]
Cannon C(2014)Induction of nerve growth factor expression and release by mechanical and inflammatory stimuli in chondrocytes: possible involvement in osteoarthritis pain Arthritis Res.Ther. 16 R16-149
[10]
Farkouh ME(2016)Nerve growth factor regulation by TNF-alpha and IL-1beta in synovial macrophages and fibroblasts in osteoarthritic mice J Immunol Res 2016 5706359-1267